FRAGMIN Drug Patent Profile
✉ Email this page to a colleague
When do Fragmin patents expire, and what generic alternatives are available?
Fragmin is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in FRAGMIN is dalteparin sodium. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dalteparin sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FRAGMIN?
- What are the global sales for FRAGMIN?
- What is Average Wholesale Price for FRAGMIN?
Summary for FRAGMIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 38 |
Drug Prices: | Drug price information for FRAGMIN |
What excipients (inactive ingredients) are in FRAGMIN? | FRAGMIN excipients list |
DailyMed Link: | FRAGMIN at DailyMed |
Recent Clinical Trials for FRAGMIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Western University, Canada | Phase 3 |
Valeo Pharma Inc | Phase 3 |
Itreas | Phase 3 |
Pharmacology for FRAGMIN
Drug Class | Anti-coagulant Low Molecular Weight Heparin |
US Patents and Regulatory Information for FRAGMIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | FRAGMIN | dalteparin sodium | INJECTABLE;INJECTION | 020287-008 | Apr 4, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer | FRAGMIN | dalteparin sodium | INJECTABLE;SUBCUTANEOUS | 020287-012 | Mar 15, 2022 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer | FRAGMIN | dalteparin sodium | INJECTABLE;SUBCUTANEOUS | 020287-005 | Apr 4, 2002 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer | FRAGMIN | dalteparin sodium | INJECTABLE;SUBCUTANEOUS | 020287-007 | Apr 4, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FRAGMIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | FRAGMIN | dalteparin sodium | INJECTABLE;SUBCUTANEOUS | 020287-001 | Dec 22, 1994 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | FRAGMIN | dalteparin sodium | INJECTABLE;SUBCUTANEOUS | 020287-004 | Jan 30, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | FRAGMIN | dalteparin sodium | INJECTABLE;SUBCUTANEOUS | 020287-003 | Mar 18, 1996 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for FRAGMIN
See the table below for patents covering FRAGMIN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 380280 | ⤷ Sign Up | |
Canada | 1136620 | FRAGMENTS D'HEPARINE AYANT UNE ACTIVITE ANTICOAGULANTE SELECTIVE (HEPARIN FRAGMENTS HAVING SELECTIVE ANTICOAGULATION ACTIVITY) | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 8001383 | ⤷ Sign Up | |
Germany | 3068924 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |